Avalo Therapeutics (AVTX) director receives stock options for 20,100 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Avalo Therapeutics director Aaron Kantoff received a new stock option grant as part of his compensation. On the grant date, he was awarded options covering 20,100 shares of Avalo Therapeutics common stock at an exercise price of $13.96 per share. These options vest 100% on the first anniversary of the grant date, as long as he continues serving as a director on that date, and expire on June 2, 2036. After this grant, his total reported stock option holdings from this award are 20,100 options, with no open-market buying or selling involved.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
KANTOFF AARON
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 20,100 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 20,100 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 20,100 options
Exercise price: $13.96 per share
Expiration date: June 2, 2036
+3 more
6 metrics
Option grant size
20,100 options
Stock options on common stock granted to director
Exercise price
$13.96 per share
Strike price for newly granted stock options
Expiration date
June 2, 2036
Options expire if not exercised by this date
Vesting schedule
100% after 1 year
Cliff vesting on first anniversary of grant, service-based
Post-transaction holdings
20,100 options
Total options reported following this grant
Transaction code
A (grant/award)
Form 4 code indicating compensation-related acquisition
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 13.9600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-02T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The stock option vests 100% on the first anniversary of the date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What transaction did Avalo Therapeutics (AVTX) director Aaron Kantoff report on this Form 4?
Aaron Kantoff reported receiving a stock option grant for 20,100 shares of Avalo Therapeutics common stock. The award is a compensation-related grant, not an open-market trade, providing the right to buy shares at a fixed exercise price in the future.
What is the exercise price and expiration date of Aaron Kantoff’s Avalo Therapeutics (AVTX) options?
The stock options have an exercise price of $13.96 per share and expire on June 2, 2036. Kantoff can only benefit from them if the options vest and Avalo’s share price exceeds the exercise price before expiration.
When do Aaron Kantoff’s Avalo Therapeutics (AVTX) stock options vest?
The options vest 100% on the first anniversary of the grant date, assuming Kantoff continues serving as a director through that date. If he does, all 20,100 options become exercisable at once rather than vesting gradually over several years.
How many Avalo Therapeutics (AVTX) options does Aaron Kantoff hold after this grant?
Following this transaction, Kantoff is reported as holding 20,100 stock options from this award. These options are direct holdings and relate to the newly granted compensation, with no additional derivative positions shown in this specific filing excerpt.